Dose Escalation Study of AST-OPC1 in Spinal Cord Injury
Clinical trial NCT02302157 · COMPLETED
Trial details
- NCT number
- NCT02302157
- Sponsor
- Lineage Cell Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2018-12-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.